Vr Adviser, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $966 Million distributed in 38 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Ocular Therapeutix, Inc with a value of $111M, Viridian Therapeutics, Inc.\De with a value of $88.3M, Applied Therapeutics Inc. with a value of $83.5M, Dyne Therapeutics, Inc. with a value of $78.1M, and Kal Vista Pharmaceuticals, Inc. with a value of $72.4M.
Examining the 13F form we can see an increase of $53.9M in the current position value, from $912M to 966M.
Vr Adviser, LLC is based out at New York, NY
Below you can find more details about Vr Adviser, LLC portfolio as well as his latest detailed transactions.
